Janus Henderson Group PLC Ardelyx, Inc. Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 25,949,323 shares of ARDX stock, worth $156 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
25,949,323
Previous 22,048,006
17.69%
Holding current value
$156 Million
Previous $161 Million
19.47%
% of portfolio
0.11%
Previous 0.09%
Shares
12 transactions
Others Institutions Holding ARDX
# of Institutions
207Shares Held
143MCall Options Held
1.01MPut Options Held
1.43M-
Black Rock Inc. New York, NY17.6MShares$105 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.7MShares$81.9 Million0.0% of portfolio
-
State Street Corp Boston, MA12MShares$71.8 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C36.9MShares$41.4 Million0.06% of portfolio
-
Eventide Asset Management, LLC Boston, MA6.67MShares$40 Million0.87% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $928M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...